Showing results (841-850 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|June 6, 2020
Drug Safety in Geriatric Patients: Current Status and Proposed Way ForwardGiovanni Furlan, Pia Caduff-Janosa, Laura Sottosanti, et al.Drug Safety|September 18, 2021
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing ExperienceLuís M Magalhães, Raquel Costa, Mariana Vieira, et al.Drug Safety|September 16, 2021
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and DiscoursePriya Bahri, Antoine ParienteDrug Safety|June 5, 2015
Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly RegistryLinda de Jonge, Hermien E K de Walle, Lolkje T W de Jong-van den Berg, et al.Drug Safety|May 14, 2015
Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013)Bianca Blanch, Nicholas A Buckley, Leigh Mellish, et al.Drug Safety|May 3, 2020
Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical StudiesArrigo F G Cicero, Roberto Pontremoli, Federica Fogacci, et al.Drug Safety|November 14, 1997
The challenge of effectively communicating risk-benefit informationI R Edwards, B HugmanDrug Safety|August 9, 2021
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UKSieta T de Vries, Petra Denig, Adriana Andrić, et al.Drug Safety|June 24, 2020
The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for PharmacovigilanceMarco Tuccori, Irma Convertino, Sara Ferraro, et al.Drug Safety|November 24, 2004
Benefit-risk assessment of ropivacaine in the management of postoperative painWolfgang Zink, Bernhard M GrafPageof 309